HOME >> MEDICINE >> NEWS
Clevidipine during heart surgery improves blood pressure control

Researchers today reported that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiologys 56th Annual Scientific Session. Another study found that measuring a certain peptide can help evaluate dyspnea (shortness of breath) as heart- or lung-related in the general population. ACC.07 is the premier cardiovascular medical meeting, bringing together specialists from around the world to further breakthroughs in cardiovascular medicine.

Blood Pressure Control With Clevidipine Compared With Nitroglycerin, Sodium Nitroprusside, or Nicardipine in the Treatment of Perioperative Hypertension: Results of the Three Randomized ECLIPSE Trials (Presentation Number: 415-8)

While nitroglycerin and sodium nitroprusside have been utilized effectively in patients undergoing cardiac surgery to control blood pressure, a new therapy called clevidipine may perform even better, according to researchers at Duke University School of Medicine. Three separate studies evaluated clevidipine, a novel third-generation intravenous (IV) dihydropyridine calcium channel blocker, to measure blood pressure control against standard alternative agents.

The studies, collectively known as ECLIPSE (Evaluation of CLevidipine In the Postoperative Treatment of Hypertension Assessing Safety Events), compared clevidipine to each of three standard therapies: nitroglycerin, nitroprusside or nicardipine. The studies assessed blood pressure control by calculating the magnitude and duration of episodes when patients blood pressure went above or below predetermined acceptable ranges, based on the area under the blood-pressure-monitoring curve (AUC) that was outside the upper or lower limits of the range during surgery and for 24 hours afterwards.

The first two ECLIPSE studies found that patients treated wi
'"/>

Contact: Leslie Humbel
lhumbel@spectrumscience.com
504-613-2418
American College of Cardiology
27-Mar-2007


Page: 1 2 3

Related medicine news :

1. Michigan-CDC study supports value of social restrictions during influenza pandemics
2. Are parking garages safe during hurricanes?
3. Smoking may interfere with alcoholics neurocognitive recovery during abstinence
4. Genetic variations may predispose some men to suicidal thoughts during treatment for depression
5. Study questions risks of anti-bleeding drug during heart surgery
6. Pfizer Onocology press briefing scheduled during ASCO 2007 Annual Meeting
7. UW study to clarify safety, effectiveness of hormone therapy during menopause
8. Eating apples and fish during pregnancy may protect against childhood asthma and allergies
9. Clinical guidelines for blood conservation during cardiac procedures developed
10. Aspirin use during pregnancy could reduce risk of pre-eclampsia
11. Will the healthcare workers go to work during disasters?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... Altec ... The Resource Group as their 2016 Microsoft Dynamics Partner of the Year at ... CA. The award recognizes The Resource Group for their outstanding relationship with ...
(Date:3/23/2017)... ... March 23, 2017 , ... ChenMed, ... announced rapid completion of the strategic executive team expansion needed to further optimize ... the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... According to ... Americans, yet poor sleep is likely not the only cause of the sunken-eye look, ... that make you look older or in poor health are likely due to genetics, ...
(Date:3/23/2017)... PA (PRWEB) , ... March 23, 2017 , ... It’s ... That means many students are thinking about summer internships , which can be ... thereof). , The pros at Garden Media Group, a boutique public relations firm outside ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is now ... pricing. Verisys through its FACIS and other services maintains the largest ... , “We are delighted to be able to offer these various products to ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company ... unmet medical needs in rare diseases, today announced that ... on Monday, April 3 during ENDO 2017, the annual ... Florida , to discuss new data regarding its ... PTH and TransCon CNP). Ascendis is presenting ...
(Date:3/23/2017)... -- Prima BioMed has presented encouraging early ... in combination with Keytruda, with one of the six ... complete response. Recruitment in the second cohort is complete ... recruited by Q317. Preliminary efficacy data from the 15-patient, ... expected mid-year (recruitment in the 226-patient Phase IIb component ...
(Date:3/23/2017)... Piramal Pharma Solutions (PPS), ... nombramiento de Stuart E. Needleman como ... integrados completa para su base de clientes farmacéuticos ... el crecimiento y ejecución de las ofertas PPS. ... todas las actividades de desarrollo empresarial global para ...
Breaking Medicine Technology:
Cached News: